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ABSTRACT 
The VoxTox research programme has applied expertise from the physical sciences to the problem of radiotherapy toxicity, 
bringing together expertise from engineering, mathematics, high energy physics (including the Large Hadron Collider), medical 
physics and radiation oncology. In our initial cohort of 109 men treated with curative radiotherapy for prostate cancer, daily image 
guidance computed tomography (CT) scans have been used to calculate delivered dose to the rectum, as distinct from planned dose, 
using an automated approach.  Clinical toxicity data have been collected, allowing us to address the hypothesis that delivered dose 
provides a better predictor of toxicity than planned dose. 
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INTRODUCTION  
An estimated 3.4 million Europeans were diagnosed 
with cancer in 2012, and globally the figure was 14.1 
million (Ferlay et al., 2015). Radiotherapy (RT) is the 
most effective non-surgical treatment for cancer (Bentzen 
et al., 2005), and 60% of those who receive it are treated 
with the objective of cure (Möller et al., 2003, IAEA 
Human Health Series, 2010). This amounts to over 2 
million people across Europe each year (Ferlay et al., 
2015), indicating the scale and importance of RT in the 
curative treatment of cancer. The success of RT in 
eradicating tumours depends chiefly on the total radiation 
dose. What limits this dose is the tolerance of the normal 
tissues surrounding the tumour. As the dose is increased 
so the incidence and severity of normal tissue damage also 
rises, and when severe, normal tissue damage can produce 
significant morbidity, which may even be life-threatening. 
Selection of the appropriate treatment is based on a 
balance between lowering the dose to keep the incidence 
of severe normal tissue complications at an acceptably 
low level, and raising the dose to increase the probability 
of tumour control.   
Complications from RT are the result of the dose 
actually delivered to the patient (Jaffray et al., 2010). In 
many circumstances this differs from the planned dose, 
for example due to daily positional variation in mobile 
internal anatomy. There is a steep dose-cure relationship, 
both in experimental animal systems and in man, and a 
5% increase in dose will typically achieve an increase in 
tumour cure in the range 5-10% (Suit, 2002). Normal 
tissue dose-toxicity relationships are even steeper, at least 
for some tissues (Barnett et al., 2009). Thus, small 
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increases in dose to tumour or reductions in dose to 
normal tissues can result in clinically valuable 
improvements, with the potential to improve quality of 
life for the individual patient and reduce society’s burden 
of care.  
We report a research study which has applied 
methodologies and expertise from the physical sciences to 
exploit ‘marginal gains’ that might follow from the use of 
delivered dose to more accurately predict toxicity in 
patients receiving radiotherapy treatment for cancer. 
THEORETICAL BACKGROUND 
Preparation of a RT plan is based on a single computed 
tomography (CT) scan performed some days before the 
start of the treatment course. However, this does not 
capture day-to-day differences resulting from internal 
organ positional change. For example, in men receiving 
curative RT for prostate cancer, the shape and position of 
the rectum, which lies immediately behind the prostate, 
are known to vary from one day to the next (de Crevoisier 
et al., 2005, Scaife et al., 2014), which alters the collateral 
dose delivered to the rectum. In one study using daily 
image guidance (IG) CT scans, accumulated delivered 
dose (DA) to the rectum was different to planned dose in 
all patients (Scaife et al., 2015). We sought to exploit the 
daily IG CT scans, which are taken every day to ensure 
accurate and reproducible treatment being delivered to the 
tumour, to calculate the daily dose delivered to the rectum 
(Figure 1). At present it is impossible to calculate this in 
routine practice, because the rectum would have to be 
contoured manually on each daily CT scan for each 
patient, which is labour-intensive, requires training, and is 
very slow. 
We hypothesised that development of specific 
computerised solutions might allow us to use image 
guidance scans to develop an individualised adaptive 
treatment approach, which could be used to reduce 
toxicity, increase tumour dose, or both. If this is to be 
developed for clinical use, then the processes of de-
archiving the IG CT data, curating them, identifying the 
rectum on each scan, computing the delivered dose DA, 
and reporting the results must be fully automated. 
Expertise has been brought together from the high energy 
physics community (in particular from the team at the 
Large Hadron Collider - LHC), engineering, applied 
                                                          
A Our initial estimate of scale was of ~60 Megabytes per scan, giving 2.4 GB of raw data per patient. Data generated during processing 
could double this, making a total volume of 4 TB for 850 patients. This was too large to be managed within the capacity available in 
the NHS radiotherapy centre at the time, but was easily accommodated in the LHC Tier 2 Centre at Cambridge. In reality, scans are 
down-sampled and some of the image guidance scans are quite short and therefore smaller, together reducing the total data volume by 
more than a factor of 10, to about 250 GB after processing. 
 
mathematics, medical physics and radiation oncology to 
develop such an automated methodology to calculate 
delivered dose to the rectum on IG CT scans. 
METHOD AND DATA 
The primary objectives of the project were to develop 
methods to calculate DA in normal tissues, and to use this 
to compare planned and delivered doses with toxicity 
experienced by individual patients during, and for a 
minimum of two years after, treatment. Therefore a 
clinical study was developed, and Ethical Committee and 
research permissions were obtained from the hospital. 
Clinical toxicity data are being collected from >850 
patients with prostate, head and neck, and central nervous 
system (CNS) tumours. We believe this is the largest such 
dataset anywhere in the world, linking toxicity outcome 
with IG imaging from which delivered doses can be 
calculated. This will allow us to go on to address the 
hypothesis that that delivered dose provides a better 
predictor of rectal toxicity than planned dose. 
Interaction between the clinical and non-clinical teams 
was needed for multiple steps, three of which presented 
major challenges (Table 1). The first related to handling a 
volume of data, originally estimated to total 
approximately 4 TBA which was too large to be managed 
within the radiotherapy centre. This task included 
retrieval, quality assurance, transfer and processing of the 
data (Figure 2). The second key challenge was to develop 
a method for automated contouring (auto-contouring) of 
the relevant critical structures, in a data set of many 
thousands of scans. In our research programme overall, 
with over 850 patients with prostate, head and neck, and 
CNS tumours, with different organs at risk in each 
anatomical site, there are 24,000 scans, containing 
316,000 CT slices, with a total of 1.1 million contours 
required. One contour is defined as a structure outlined on 
1 slice in a CT scan. Contouring of such a large number 
of scans would be impossible by hand: assuming that each 
contour takes an expert 1 minute to complete, this would 
take 1 million minutes, or 1.9 person-years. Moreover, the 
final objective is for this to be done in real time for clinical 
application, which cannot realistically rely on expert 
human operators. The third major challenge is the 
recalculation of the dose using the IG CT scans, which is 
a computationally very intensive task (see below). 
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Fig. 1. Planning kV CT scan (A) and scan-of-the day image guidance TomoTherapy HiArt™ MV CT scan (B), at the same level in the 
same patient receiving curative radiotherapy for prostate cancer. Note that the rectum (arrowed) is of modest size at the time of the 
planning scan, but dilated principally with air in the treatment scan. 
Tab. 1. Areas of interaction required between the clinical and the physics environment. The major challenges are shown with ‘*’. The 
first was the general challenge of handling volumes of data, originally estimated to total approximately 4 TB, which was too large to be 
managed within the radiotherapy centre. Not only storage, but also curation and processing of the data, was required (Figure 2). 
1 
De-archiving of image guidance (IG) CT scans, and associated data, from manufacturer’s proprietary archive, including 
alterations required with new versions of the archive software structure; extraction of planning CT scan data from separate 
archive, and correlation of the two data sets 
2 Tokenisation & export of each patient’s data set through hospital firewall 
3 Data storage, curation and processing at High Energy Physics group * 
4 Auto-contouring of rectum on IG CT scans * 
5 Dose calculation of rectal dose on each daily IG CT scan, using auto-contouring application (Python & MatLab) * 
6 Toxicity score mapping to accumulated dose (DA) 
7 Automation of control of processes 3-5 
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Fig. 2. VoxTox data flows. kV, kilovoltage; MV, megavoltage; DA Accumulated dose. 
Proof-of-concept patient cohort 
We commenced with a cohort of patients who had 
received curative RT for prostate cancer, with a special 
focus on delivered dose to the rectum. We selected 109 
patients, each treated to a median dose of 74 gray (Gy) in 
37 fractions, delivered on 5 days per week over 7½ weeks. 
All patients were imaged with on-board CT and positional 
correction was made immediately prior to treatment. 
Treatment was delivered with intensity modulated RT 
(Mackie, 2006, Burnet et al., 2010). 
Manual contours for comparison with automated 
contouring algorithm 
The first step in developing an automated method to 
auto-contour the rectum was to create a set of manual 
rectal contours to which the automated system could be 
compared. For 10 patients, the rectum was contoured on 
all 37 daily IG scans by 1 operator (JES), who had a 
median intra-observer Jaccard Conformity Index (JCI) for 
contouring of 0.87B .  Random variation in rectal position 
during radiotherapy for prostate cancer was seen to be two 
                                                          
B For 2 intersecting sets, A and B, the Jaccard Conformity Index (also known as the Jaccard index, Jaccard similarity coefficient, 
concordance index, and initially described by Paul Jaccard as the ‘coefficient de communauté’ (Hanna et al., 2010)), is defined as the 
size of the intersection divided by the size of the union of A and B: J(A, B) = A ∩  BA ∪  B 
 
to three times greater than that predicted from inter-
fraction motion of the prostate (Scaife et al., 2014), and 
differences between planned and accumulated dose to the 
rectum were seen in all 10 participants (Scaife et al., 
2015). These data were also used to estimate the potential 
value to patients (Scaife et al., 2015, Barnett et al., 2015). 
To assess inter-operator variation, one IG scan in another 
6 patients was contoured by 8 consultant oncologists 
specialising in prostate radiotherapy, who showed a 
median inter-observer JCI of 0.79. 
Automated processing pipeline 
A system for automated control was required for all 
the steps in the process of calculating accumulated 
delivered dose, to perform automated batch processing of 
image retrieval from our data store, rectal auto-
contouring, dose re-calculation and dose-volume 
reporting. Computing models for petabyte-scale data 
analysis in experiments at the LHC were used in 
developing a data-processing system for the VoxTox 
study. A software framework has been implemented to 
allow a wide range of computing tasks to be carried out 
efficiently (Barrand et al., 2001). Although the framework 
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itself is run in Python, algorithms may wrap code in other 
languages, such as Matlab, used for some of our processes 
(Thomas et al., 2011, Thomas et al., 2016). The 
computing jobs for a full-scale analysis are tracked using 
Ganga (Gaudi and Grid Alliance) (Mościcki et al., 2009). 
This system provides an efficient solution for the analysis 
work, involving just over 250GB of data, and would scale 
easily for use in our follow-on studies, with significantly 
higher data volumes. 
Automation of patient imaging extraction 
In order to manage the volume of data, we 
implemented a bespoke automated software solution to 
locate patients consented for the study, extract patient data 
directly from the electronic archives without having to use 
clinical pathways (Romanchikova et al., 2017), remove all 
personal-identifiable information, assign a study-specific 
patient identifier (token), and convert the extracted data to 
Digital Imaging and Communication in Medicine 
(DICOM) format. The insertion of the token is essential 
for later correlation with clinical toxicity data collected 
over time. Data on positional corrections applied during 
each image guidance procedure were included in the 
exported data to improve the accuracy of the image 
registration and facilitate calculation of DA. The 
anonymised DICOM imaging data were then transferred 
to the Physics facilities for storage, curation and 
processing in our LHC Tier 2 Centre. 
Automated contouring 
Another important use for the manual contour data set 
was to define search boundaries to provide a starting point 
for the automated algorithm (Scaife et al., 2015, Cai et al., 
2016). The automated contouring algorithm itself is based 
on the method developed by Chan and Vese in 2001 for 
segmenting non-medical images (Chan and Vese, 2001). 
This requires a good initialisation, achieved by registering 
the manual contour from the planning scan onto the image 
guidance scan. Although our own developments have 
improved the overall performance, we regard this as only 
an interim solution (Sutcliffe et al., 2015, Scaife, 2016, 
Simmat et al., 2012, Whitfield et al., 2013). At the level 
of the prostate itself, the imaging cannot distinguish the 
anterior border of the rectum from the posterior edge of 
the prostate. However, since these 2 structures are 
anatomically fixed, we use the anterior part of the contour 
from the planning scan to provide this border (Cai et al., 
2016, Sutcliffe et al., 2015, Scaife, 2016). 
Recalculation of accumulated delivered dose (DA) 
using the IG scans 
We use our in-house independent calculation system 
(Thomas et al., 2011) to re-calculate the DA for each 
fraction, for each patient, based on the IG CT scan, and 
the patient position correction shifts, extracted from the 
archive (Thomas et al., 2016). The daily DA is converted 
to a dose-surface map (DSM) (Buettner et al., 2009), 
which can be summed to provide cumulative DA and a 
dose difference map. The system can be run on a cluster 
of independent machines, without user intervention, and 
without tying up the clinical planning system. 
RESULTS 
Evaluation of automated contouring algorithm  
In order to assess the effectiveness of the automated 
auto-contouring algorithm, in our cohort of 109 patients, 
all CT slices from one randomly selected megavoltage 
(MV) scan for each patient were visually evaluated 
against the objective of >70% of contours being 
acceptable (Lu et al., 2006). Out of 1107 slices in total, 
821 (74%) were found to be acceptable. 
The auto-contouring was compared to manual 
contours on 370 scans from 10 patients, and performed 
with a median JCI of 0.79 (IQR 0.74 to 0.79) (Figure 3) 
(Scaife et al., 2015). Auto-contouring was also compared 
to 8 consultant oncologists and performed with a median 
JCI per scan of 0.64 (IQR 0.53-0.71) (Figure 4) (Scaife, 
2016). 
Although performance of the automated algorithm 
was generally successful, there were discrepancies that we 
wish to remove. This is especially important since 
ultimately we aim to implement a method for altering a 
patient’s treatment based on the automated contours. 
Work is in progress to develop this further by: firstly, 
segmenting the treatment scan in three dimensions rather 
than slice by slice; secondly, using manual segmentation 
from the planning scan, combined with anatomical and 
biomechanical knowledge of the organ to define a ‘shape 
prior’; thirdly, rendering the computational solution 
feasible and robust by replacing the non-convex energy 
by a sequence of convex energies (Cai et al., 2013), 
making the auto-contour less sensitive to spurious 
suboptimal contours and poor initialisation; and fourthly, 
integrating a machine learning-framework, to achieve an 
automated choice of model parameters (Calatroni et al., 
2015, Criminisi and Shotton, 2013). Nevertheless, we are 
not aware of any other fully automated solution to contour 
the rectum on image guidance scans that can deliver 
results comparable to our system, making this a ground-
breaking development. 
Proof-of-concept patient cohort results 
The system was tested on our 109 prostate patient 
cohort, for which there is median 4 year follow up, with 
late rectal toxicity data collected prospectively. The 
planning scan, and 37 image guidance CTs (totalling 
4033), were retrieved, automated contouring of the 
rectum was performed, and the image guidance scans 
were used to compute DA. The entire process took 94 
hours for the 109 patients, an average of 52 minutes per 
NG Burnet et al. 8
 
patient. However, this was achieved using approximately 
240 machines in parallel. The average time for the dose 
calculation on the MV CT scans is about 6 hours per MV 
scan per patient, using a single machine. Although slow, 
this would still allow calculation of daily accumulated 
dose overnight, before the next treatment is delivered. 
Our results suggest a small improvement in correlation 
between dose and probability of rectal toxicity (bleeding) 
for accumulated delivered dose compared to planned 
dose, and details will be presented elsewhere (Shelley et 
al., 2017). 
 
 
Fig. 3. Frequency distribution of JCI for 370 MV CT scans in 10 patients (~40,000 slices), compared to a single expert operator. The 
median JCI per scan was 0.64 (range 0.12 – 0.94). 
 
Fig. 4. Example of an MV CT slice of the centre of the pelvis, 
showing rectal contours from eight senior radiation oncologists 
(red - median inter-observer JCI of 0.79.) and the automated 
algorithm (yellow). The median JCI for the automated system 
for this slice was 0.64. However, visually, the degree of 
agreement is striking. 
Ant - Anterior (front of the patient), Post – posterior (back of 
the patient), Left – left side of the patient (shown on the right 
of the screen by convention), Right – right of the patient. 
DISCUSSION AND CONCLUSIONS 
To address the challenge of calculating accumulated 
delivered dose (DA) as distinct from planned radiation 
dose, in order to improve toxicity predictions in patients 
receiving radiotherapy for cancer, we brought together a 
group that applied physical science expertise to medical 
questions.  
Collaboration between oncologists and medical 
physicists is a routine part of clinical care for patients 
receiving radiotherapy. The collaboration with 
engineering and high energy physics, later expanded to 
include mathematics, was the result of finding 
researchers with an interest in the application of science 
to a wider context, including people with cancer.  Having 
researchers collaborating from different disciplines and 
backgrounds stimulated novel approaches to problem-
solving which would not otherwise have occurred. 
The links between the groups, emphasising the 
multidisciplinary teamwork, are shown in Figure 5 (see 
also Fig 2).  At the outset the Programme was divided 
into 5 workstreams (WS): WS0 – programme 
management; WS1 – extraction of imaging data, 
calculating delivered dose, modelling toxicity risk; WS2 
– curation and storage of data, image segmentation and 
biomechanical modelling, integration of daily DA 
calculation; WS3 – collection and analysis of clinical 
toxicity data; WS4 – in silico modelling of irradiated 
normal tissue cells in luminal structures.  The concept 
0
5
10
15
20
25
30
35
0-
0.
05
0.
06
-0
.1
0.
11
-0
.1
5
0.
16
-0
.2
0.
21
-0
.2
5
0.
26
-0
.3
0.
31
-0
.3
5
0.
36
-0
.4
0.
41
-0
.4
5
0.
46
-0
.5
0.
51
-0
.5
5
0.
56
-0
.6
0.
61
-0
.6
5
0.
66
-0
.7
0.
71
-0
.7
5
0.
76
-0
.8
0.
81
-0
.8
5
0.
86
-0
.9
0.
91
-0
.9
5
0.
96
-1
.0
Fr
eq
ue
nc
y
Jaccard Conformity Index
Auto-contouring accuracy: Jaccard Conformity Index 
for automated contours versus human operator
Applying physical science techniques and CERN technology to an unsolved problem in radiation 
treatment for cancer: the multidisciplinary ‘VoxTox’ research programme 
 9 
and design of these individual workstreams arose from 
detailed and iterative discussions between the different 
disciplines, focussed on a real clinical problem, and 
using or developing clinically applicable (i.e. not 
research-restricted) algorithms. 
Organisationally, the group meet for 3 monthly 
Progress Meetings, bringing the whole group together to 
present and, importantly, discuss active components of 
the programme and their results.  This has been highly 
effective in exchanging information between 
workstreams, guiding the direction of the work, and 
maintaining enthusiasm in the group.  In addition, regular 
informal meetings take place (fortnightly), some of 
which serve as multi-disciplinary PhD supervision 
meetings.  Informal meetings with the medical 
statisticians occur about every 2 months, to address 
specific statistics questions. The groups are housed at 3 
different campuses in Cambridge, so regular, frequent, 
formal and informal meetings have been an important 
aspect of the collaboration.  The programme is overseen 
by a Programme Board, who determine over-arching 
science policy and compare progress to the deliverables 
set at the beginning of the Programme. 
For the Progress Meetings, anyone working in a 
similar area is encouraged to attend.  This includes 
undergraduates and postgraduates linked to the VoxTox 
Programme (10 undergraduate projects, 1 PhD and 2 
MPhils awarded, 2 PhDs and 1 MPhil underway).  The 
group has also contributed to the annual ‘Physics at 
Work’ outreach event for schoolchildren (reaching > 500 
students and teachers each year), and the Programme has 
driven 1 international and 2 national symposia. 
 
 
 
 
Fig. 5. Administrative and scientific multidisciplinary connections, together with data flows used in the Programme.  Background colours 
indicate on which campus each group is located.
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Automated analysis has been applied to daily IG CT 
scans. Accurate segmentation of soft tissues is very 
challenging because these scans intrinsically have a 
lower diagnostic quality than planning CT scans due to 
higher noise and low soft tissue contrast. However, IG 
CT scans are of good enough quality to see the 
boundaries of the rectum, and they are used routinely for 
IG in clinics around the world. Where the anterior rectal 
wall cannot be distinguished from the prostate, human 
anatomical structure permits use of the contour from the 
planning scan. Deformable registration is a technique 
that cannot reliably be used to determine rectal size and 
position (Simmat et al., 2012, Godley et al., 2013). 
Automation also has the potential to improve the 
reliability and speed of adaptive treatment. 
Although it would be attractive to use an imaging 
modality with higher quality, for example magnetic 
resonance imaging (MRI), such imaging needs to be 
performed at the time of treatment and in the treatment 
position. Although MRI-linear accelerators are now 
being deployed, they are comparatively expensive and 
few in number, and there is as yet no evidence on their 
role in improving RT. It is unlikely that there will ever 
be sufficient machines to treat all European men 
requiring RT for prostate cancer, and CT-based systems 
will remain the mainstay at least for the immediate 
future. There is thus potential value for patients and 
society in developing the use of IG imaging based on CT 
technology. 
A better understanding of the relationship between 
delivered dose and planned dose offers the potential to 
improve predictions of toxicity. If differences can be 
identified during a course of treatment then the 
possibility arises to adapt an individual patient’s 
treatment based on the delivered dose and associated 
toxicity prediction. For men receiving curative RT for 
prostate cancer, demonstration of a difference between 
delivered and planned dose would be potentially 
valuable, to allow either dose escalation to the tumour 
(for lower than expected toxicity risk) or re-planning to 
abrogate excess risk to the rectum (for patients with risk 
higher than expected). Across the population this could 
lead to more men being cured and fewer suffering from 
complications of treatment, even though toxicity has 
been significantly reduced by the use of modern 
radiotherapy techniques. 
The development of a methodology based on 
sophisticated computing rather than highly trained staff 
was considered essential to maximise reproducibility on 
a large patient cohort, to reduce inter-observer variability 
and to elimination the human error associated with 
manual processing. It may also facilitate deployment in 
today’s economic climate. 
The collection of toxicity data from patients in our 
clinical study has provided us with the largest resource 
of patient IG imaging linked with toxicity information 
anywhere in the world. This has allowed us to start 
addressing the hypothesis that delivered dose provides a 
better predictor of toxicity than planned dose (Shelley et 
al., 2017). 
Conclusions 
Links between departments and effective knowledge 
exchange have been essential in our research 
programme. Although needing further refinement, our 
approach allows automated contouring of the rectum and 
calculation of the daily delivered dose, for comparison 
with the planned dose. Inter-disciplinary expertise has 
added considerable value, allowing us to tackle a major 
challenge related to improving the outcome of patients 
with cancer, by more accurately predicting the risk of a 
patient developing toxicity. 
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